Source: Eur Respir J 2008; 31: 416-469
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cazzola M., MacNee W., Martinez F. J., Rabe K. F., Franciosi L. G., Barnes P. J., Brusasco V., Burge P. S., Calverley P. M. A., Celli B. R., Jones P. W., Mahler D. A., Make B., Miravitlles M., Page C. P., Palange P., Parr D., Pistolesi M., Rennard S. I.,. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416-469

Member's Comments

No comment yet.

Related content which might interest you: Outcomes for COPD pharmacological trials: from lung function to Biomarkers Source: Guideline 2008 Year: 2008 Outcomes for COPD pharmacological trials: from lung function to Biomarkers Source: ERS Live 2008 Year: 2008 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Lung function decline in COPD trials Source: Eur Respir J 2009; 33: 708-709 Year: 2009 FEV6: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004 Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness Source: International Congress 2014 – COPD: points to ponder Year: 2014 The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts Source: ERJ Open Res, 7 (1) 00531-2020; 10.1183/23120541.00531-2020 Year: 2021 Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Lung function values as predictors for outcome during non-invasive ventilation in COPD patients Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016